Inventor · disambiguated record
Andre Jomard
Also filed as: JOMARD ANDRE · JOMARD ANDRé
21 granted patents·14 pending applications·127 citations·filing 1996–2017
94Inventor score
Files withGALDERMA RES & DEV17GALDERMA SA5CIRD GALDERMA4RETHORE SANDRINE2GALDERMA RECH DERMATOLOGIQUE1
Top patents by PatentIndex Score
35 records- 0180US8227514B2Topical application of travoprost for combating hair lossRETHORE SANDRINE·Filed 2010·Granted Jul 24, 2012·7 cites·10 claims
- 0280US7125869B2Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Oct 24, 2006·4 cites·81 claims
- 0378US7307078B2Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 11, 2007·3 cites·81 claims
- 0478US7285568B2Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Oct 23, 2007·4 cites·14 claims
- 0575US7452878B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Nov 18, 2008·2 cites·15 claims
- 0673US8669233B2Combination of compounds for treating or preventing skin diseasesJOMARD ANDRE·Filed 2010·Granted Mar 11, 2014·4 cites·10 claims
- 0770US7312249B2Vitamin D analoguesGALDERMA RES & DEV·Filed 2005·Granted Dec 25, 2007·1 cites·162 claims
- 0870US6280755B1Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammalsOREAL·Filed 1998·Granted Aug 28, 2001·26 cites·22 claims
- 0967US6248749B1Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiationGALDERMA RECH DERMATOLOGIQUE·Filed 1997·Granted Jun 19, 2001·24 cites·7 claims
- 1063US8980948B2Topical application of travoprost for combating hair lossRETHORE SANDRINE·Filed 2012·Granted Mar 17, 2015·0 cites·12 claims
- 1162US9186358B2Combination therapy for treating or preventing an inflammatory skin disorderJOMARD ANDRé·Filed 2010·Granted Nov 17, 2015·3 cites·2 claims
- 1262US6004987AUse of ligands which are specific for RXR receptorsCIRD GALDERMA·Filed 1996·Granted Dec 21, 1999·19 cites·18 claims
- 1359US7807669B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2008·Granted Oct 5, 2010·0 cites·16 claims
- 1459US2011150774A1Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1556US11234959B2Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczemaGalderma Holding SA·Filed 2017·Granted Feb 1, 2022·0 cites·9 claims
- 1655US10874682B2Compositions and the use thereof for treating or preventing rosaceaNESTLE SKIN HEALTH SA·Filed 2017·Granted Dec 29, 2020·0 cites·9 claims
- 1755US5973007AUse of inhibitors of retinoic acid activity for wound healingCIRD GALDERMA·Filed 1997·Granted Oct 26, 1999·13 cites·12 claims
- 1854US2007065471A1Cosmetic/dermatological applications of PPAR receptor activatorsGALDERMA RES & DEV·Filed 2006·Application pending·0 cites
- 1954US2010124538A1Topical application of fluocinolone acetonide for depigmentation of the skinGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2052US10398720B2Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitisGALDERMA SA·Filed 2017·Granted Sep 3, 2019·0 cites·11 claims
- 2150US2017000812A1Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitisGALDERMA SA·Filed 2014·Application pending·0 cites
- 2250US2014249096A1Combination of compounds for treating or preventing skin diseasesGALDERMA RES & DEV·Filed 2014·Application pending·0 cites
- 2348US2009111783A1Dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin for treating the hyperpigmentation of pathological scarsGALDERMA SA·Filed 2008·Application pending·0 cites
- 2447US7582663B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Granted Sep 1, 2009·0 cites·18 claims
- 2547US5827500AProcess for identifying RAR-receptor-antagonist compoundsCIRD GALDERMA·Filed 1996·Granted Oct 27, 1998·11 cites·8 claims
- 2647US2008219936A1Skin depigmenting compositions comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agentGALDERMA RES AND DEV·Filed 2008·Application pending·0 cites
- 2746US9408793B2Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositionsGALDERMA RES & DEV·Filed 2013·Granted Aug 9, 2016·0 cites·18 claims
- 2845US2016054319A1Method for detecting trichophytons and associated diseasesGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 2941US2006009426A1Pharmaceutical compositions comprising calcitriol and a clobetasol propionateGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 3040US5696104AProcess for identifying RXR-receptor-agonist compoundsCIRD GALDERMA·Filed 1996·Granted Dec 9, 1997·6 cites·14 claims
- 3139US2009018108A1Treating skin hyperpigmentation with dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoinGALDERMA SA·Filed 2008·Application pending·0 cites
- 3236US2014275108A1Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 3335US2011166113A1Method for treating the hyperpigmentation of pathological scarsGALDERMA SA·Filed 2011·Application pending·0 cites
- 3431US2008159969A1Pharmaceutical Or Cosmetic Composition Comprising Mequinol And At Least One Depigmenting AgentGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 3531US2005163731A1Skin depigmenting compositions comprising adapalene and at least one depigmenting active agentGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →